Back
Syros Pharmaceuticals Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
25
SYRS
Syros Pharmaceuticals
Last Price:
$0.21
Seasonality Move:
5.18%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and SYRS is experiencing slight selling pressure.
Syros Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.22 | Sell |
| 20-day SMA: | 0.24 | Sell |
| 50-day SMA: | 1.2 | Sell |
| 200-day SMA: | 3.65 | Sell |
| 8-day EMA: | 0.22 | Sell |
| 20-day EMA: | 0.38 | Sell |
| 50-day EMA: | 0.99 | Sell |
| 200-day EMA: | 2.97 | Sell |
Syros Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 29.13 | Sell |
| Chaikin Money Flow: | -1378990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.21 - 0.27) | Sell |
| Bollinger Bands (100): | (0.47 - 3.07) | Sell |
Syros Pharmaceuticals Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Syros Pharmaceuticals Stock
Is Syros Pharmaceuticals Stock a Buy?
-
Syros Pharmaceuticals share price is 0.21 while SYRS 8-day simple moving average is 0.22, which is a Sell signal.
-
The stock price of SYRS is 0.21 while Syros Pharmaceuticals 20-day SMA is 0.24, which makes it a Sell.
-
Syros Pharmaceuticals 50-day simple moving average is 1.20 while SYRS share price is 0.21, making it a Sell technically.
-
SYRS stock price is 0.21 and Syros Pharmaceuticals 200-day simple moving average is 3.65, creating a Sell signal.
SYRS Technical Analysis vs Fundamental Analysis
Sell
25
Syros Pharmaceuticals (SYRS)
is a Sell
Is Syros Pharmaceuticals a Buy or a Sell?
-
Syros Pharmaceuticals stock is rated a SellThe current Syros Pharmaceuticals [SYRS] share price is $0.21. The Score for SYRS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Syros Pharmaceuticals Stock Info
Market Cap:
5.5M
Price in USD:
0.21
Share Volume:
2.8M
Syros Pharmaceuticals 52-Week Range
52-Week High:
8.17
52-Week Low:
0.18
Sell
25
Syros Pharmaceuticals (SYRS)
is a Sell
Syros Pharmaceuticals Share Price Forecast
-
What is the Syros Pharmaceuticals stock price today?The Syros Pharmaceuticals stock price is 0.21 USD today.
-
Will SYRS stock go up or go down?Syros Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Syros Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Syros Pharmaceuticals is overvalued.
Is Syros Pharmaceuticals Stock a Buy?
-
Syros Pharmaceuticals share price is 0.21 while SYRS 8-day exponential moving average is 0.22, which is a Sell signal.
-
The stock price of SYRS is 0.21 while Syros Pharmaceuticals 20-day EMA is 0.38, which makes it a Sell.
-
Syros Pharmaceuticals 50-day exponential moving average is 0.99 while SYRS share price is 0.21, making it a Sell technically.
-
SYRS stock price is 0.21 and Syros Pharmaceuticals 200-day simple moving average is 2.97, creating a Sell signal.
Fundamental Analysis of Syros Pharmaceuticals
Is Syros Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and a decrease next year of $0.85 per share.
Technical Analysis of Syros Pharmaceuticals
Should I short Syros Pharmaceuticals stock?
-
SYRS Moving Average Covergence Divergence (MACD) indicator is -0.26, suggesting Syros Pharmaceuticals is a Sell
-
Syros Pharmaceuticals Relative Strength Index (RSI) is 29.13, which suggest Syros Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Syros Pharmaceuticals is (0.21 - 0.27), which suggest Syros Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Syros Pharmaceuticals is (0.47 - 3.07), which suggest Syros Pharmaceuticals is a Sell
* Syros Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.